S
UBX

SignatureFD’s Unity Biotechnology UBX Stock Holding History

SignatureFD’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200
Closed -$77 – 3485
2025
Q2 		$77 Hold
200
– – ﹤0.01% 3209
2025
Q1 		$208 Hold
200
– – ﹤0.01% 3243
2024
Q4 		$195 Hold
200
– – ﹤0.01% 3226
2024
Q3 		$294 Hold
200
– – ﹤0.01% 3146
2024
Q2 		$270 Hold
200
– – ﹤0.01% 3039
2024
Q1 		$328 Hold
200
– – ﹤0.01% 3063
2023
Q4 		$386 Hold
200
– – ﹤0.01% 2997
2023
Q3 		$480 Hold
200
– – ﹤0.01% 3029
2023
Q2 		$510 Hold
200
– – ﹤0.01% 3071
2023
Q1 		$326 Hold
200
– – ﹤0.01% 3143
2022
Q4 		$548 Hold
200
– – ﹤0.01% 3090
2022
Q3 		$1K Hold
200
– – ﹤0.01% 3042
2022
Q2 		$1K Hold
200
– – ﹤0.01% 3026
2022
Q1 		$2K Hold
200
– – ﹤0.01% 2868
2021
Q4 		$3K Buy
+200
New +$4.37K ﹤0.01% 2625

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

SignatureFD's UBX Position: Q3 2025 in Review

SignatureFD sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 200 shares — an estimated $77 sold.

SignatureFD first reported a position in UBX in Q4 2021 and held it in 15 quarters. The position peaked at $3K in Q4 2021. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • SignatureFD reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • SignatureFD sold 200 Unity Biotechnology shares in Q3 2025, an estimated $77.
  • SignatureFD first reported a position in Unity Biotechnology in Q4 2021 and held it in 15 quarters.
  • SignatureFD's Unity Biotechnology position peaked at $3K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on SignatureFD's 13F filing for Q3 2025, filed 21 Oct 2025.